PPHM

Peregrine Pharmaceuticals Inc. News Headlines

$1.66
*  
unch
unch
Get PPHM Alerts
*Delayed - data as of Aug. 27, 2014  -  Find a broker to begin trading PPHM now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

A Biotech Winner For 2013
2/21/2013 8:25:00 PM - Seeking Alpha

Update on Peregrine's Bavituximab - Analyst Blog
2/20/2013 2:50:01 PM - Zacks.com

VIX - Options Volatility And Market Sonar: Tuesday Recap
2/19/2013 4:39:00 PM - Seeking Alpha

Largest option buying in equities so far
2/19/2013 12:06:06 PM - optionMONSTER

Data on Peregrine's Bavituximab - Analyst Blog
2/14/2013 5:00:01 PM - Zacks.com

Today's Market News To Trade On: 5 Stocks Moving On News
2/14/2013 7:57:00 AM - Seeking Alpha

Priority FDA Review for Celgene Drug - Analyst Blog
2/12/2013 5:40:01 PM - Zacks.com

Gilead Closes YM Biosciences Buyout - Analyst Blog
2/11/2013 7:13:01 PM - Zacks.com

Protalix Exploring Options - Analyst Blog
2/7/2013 7:15:01 PM - Zacks.com

Pipeline Setback for Idenix - Analyst Blog
2/7/2013 6:10:01 PM - Zacks.com

Medivation's Xtandi Impresses - Analyst Blog
2/7/2013 5:30:01 PM - Zacks.com

Speculative Biotech Stocks That Could Bounce
2/7/2013 3:57:00 PM - Seeking Alpha

Vivus Unveils Qsymia Study Results - Analyst Blog
2/7/2013 2:40:01 PM - Zacks.com

Gilead Beats Estimates in 4Q - Analyst Blog
2/5/2013 10:30:01 AM - Zacks.com

Canada Approves Seattle Genetics' Adcetris - Analyst Blog
2/4/2013 6:44:21 PM - Zacks.com

Alnylam Prices Public Offering - Analyst Blog
1/16/2013 5:40:01 PM - Zacks.com

Alnylam to Raise $125 Million - Analyst Blog
1/15/2013 6:04:01 PM - Zacks.com

Geron's Update on Stem Cell Assets - Analyst Blog
1/10/2013 3:00:01 PM - Zacks.com

REGN Predicts Eylea Growth in 2013 - Analyst Blog
1/9/2013 9:50:01 AM - Zacks.com

Peregrine Recovers As Phase II Trial Is Salvaged
1/9/2013 9:18:00 AM - Seeking Alpha

4 Biotechnology Stocks With Upcoming Catalysts
1/9/2013 8:51:00 AM - Seeking Alpha

Tuesday's Small Cap Biopharma Investment And Catalyst Trade List
1/8/2013 8:25:00 AM - Seeking Alpha

Today's Market News To Trade On: 5 Stocks Moving On News
1/8/2013 8:10:00 AM - Seeking Alpha

Peregrine Pharmaceutical's Big Jump
1/7/2013 12:04:00 PM - Seeking Alpha

Peregrine Pharmaceuticals Beats Earnings Estimates
12/11/2012 11:16:00 AM - Seeking Alpha